Prior to coming to Cambridge, Qi gained valuable experience in statistical analysis and integration of multi-omics data at Imperial College London. Since she joined the University of Cambridge, she led a large-scale genome-wide association study and meta-analysis of multiple studies of breast cancer survival for Breast Cancer Association Consortium.
Qi has strong research interests in identification of genetic variation linked with human diseases and various traits and integration of multi-omics data. She is also interested in understanding the causal relationships between modifiable exposures and outcome of interest.
Guo Q, +134 co-authors., “Body Mass Index and Breast Cancer Survival: A Mendelian Randomisation Analysis”. International Journal of Epidemiology, 46(6): 1814–1822, 2017.
Milne R, … Guo Q, et al., “Identification of ten variants associated with risk of estrogen receptor negative breast cancer”, Nature Genetics, 49(12): 1767-1778, 2017.
Jiao X, …Guo Q, et al., ”PHIP – a novel candidate breast cancer susceptibility locus on 6q14.1”, Oncotarget, 2017: 8(61):102769-102782.
Fagerholm R, … Guo Q, et al., “TP53-based interaction analysis identifies cis-eQTL variants for TP53BP2, FBXO28, and FAM53A that associate with survival and treatment outcome in breast cancer”, Oncotarget, 2017: 14;8(11):18381-18398.
Guo Q, +150 co-authors, Identification of novel genetic markers of breast cancer survival. J. Natl. Cancer Inst. 2015;107(5).
Pirie A, Guo Q, et al., Common germline polymorphisms associated with breast cancer-specific survival, Breast Cancer Res. 2015; 17(1): 58.
Jamshidi M, …Guo Q, et al., SNP-SNP interaction analysis of NF-κB signaling pathway on breast cancer survival. Oncotarget. 2015;6(35):37979-94.
Guo Q, et al., Replication of Genetic Polymorphisms Reported to Be Associated with Taxane-Related Sensory Neuropathy in Patients with Early Breast Cancer Treated with Paclitaxel—response. Clin Cancer Res. 2015;21(13):3094.
Abraham J*, Guo Q*, et al., Replication of genetic polymorphisms reported to be associated with taxane-related sensory neuropathy in patients with early breast cancer treated with Paclitaxel. Clin Cancer Res, 2014; 20(9):2466-75. (*joined first author)